Therapeutic response and outcomes of systemic lupus erythematosus complicated with severe thrombocytopenia

Qianru Zhang,Wei Zhou

DOI: https://doi.org/10.3760/cma.j.issn.1673-4777.2017.04.016

2017-01-01

Abstract:Objective To analyze clinical characteristics,therapeutic response and outcomes of systemic lupus erythematosus (SLE) complicated with severe thrombocytopenia.Methods Twenty-nine SLE patients with severe thrombocytopenia in Peking University First Hospital from January 2009 to April 2015 were retrospectively analyzed.The patients were divided into good therapeutic response group(platelet count ≥ 80 × 109/L,19 cases) and poor therapeutic response group (platelet count ＜ 80 × 109/L,10 cases) after treament with consequence of glucocorticoid and immunosuppressive agents.Clinical characteristics,laboratory indexes,disease activity[SLE Disease Activity Index(SLEDAI)] and outcomes were recorded.Results Platelet count,hemoglobin level,white blood cell count,anti-dsDNA antibody titer,anti-nRNP antibody positive rate,anti-rRNP antibody positive rate,anti-SSA antibody positive rate,anti-SSB antibody positive rate,anticardiolipin antibody positive rate and C3,C4 levels had no significant differences between groups before treatment (P ＞ 0.05).Platete count in poor therapeutic response group was significantly lower than that in good therapeutic response group after treatment[(27 ± 13) × 109/L vs(148 ±58) × 109/L] (P ＜0.01).The incidence of bleeding had no significant difference between groups (P ＞ 0.05).The SLEDAI score had no significant difference between groups(P ＞ 0.05).There were 3 death(30.0％) caused by severe infection and 3 loss of follow-up(30.0％) in poor therapeutic response group;the mean follow-up time of 4 cases was (10 ± 9) months;the mean platelet count in final follow-up was (145 ± 124) × 109/L,with 2 cases of normal platelet count.There were 5 loss of follow-up(26.3％) in good therapeutic response group;the mean follow-up time of 14 cases was (24 ± 19) months;the mean platelet count in final follow-up was (193 ± 53) × 109/L.Conclusions Severe hemorrhage is not common in SLE complicated with severe thrombocytopenia.Long-term therapeutic effect of glucocorticoid is good.The major cause of death is infection.